Aclaris Therapeutics
ACRS
ACRS
104 hedge funds and large institutions have $694M invested in Aclaris Therapeutics in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 23 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 110 → 104 (-6)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
Holders
104
Holding in Top 10
5
Calls
$3.8M
Puts
–
Top Buyers
| 1 | +$27.3M | |
| 2 | +$18.9M | |
| 3 | +$15M | |
| 4 |
BlackRock
New York
|
+$11.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.9M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$13.4M | |
| 3 | -$13.2M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$6.37M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$5.83M |